Department of Dental Basic Education, School of Dentistry, Asahi University, Mizuho, Gifu, Japan.
Biol Pharm Bull. 2012;35(6):988-92. doi: 10.1248/bpb.35.988.
The cardiotoxic effects of local anesthetics increase in cardiac ischemia which is characterized by the tissue pH lowering to 6.5 or less. Apart from the cardiac channel blockade, the membrane interaction has been referred to as another mode of their cardiotoxic action. By using biomimetic membranes, we verified the hypothesis that bupivacaine and lidocaine may increasingly interact with cardiac mitochondrial membranes under ischemia-like acidic conditions. Biomimetic membranes were prepared with different phospholipids and cholesterol to be unilamellar vesicles suspended in buffers of pH 7.4, 6.9, 6.4 or 5.9. Bupivacaine and lidocaine were reacted with the membrane preparations at cardiotoxically relevant concentrations and their membrane interactivities were determined by measuring fluorescence polarization. Both drugs interacted with 100 mol% 1,2-dipalmitoylphosphatidylcholine, peripheral nerve cell-mimetic and cardiomyocyte-mimetic membranes to increase membrane fluidity, although lowering the reaction pH from 7.4 to 5.9 decreased their membrane-fluidizing effects. In cardiomyocyte mitochondria-mimetic membranes containing 20 mol% cardiolipin, however, bupivacaine and lidocaine reversely increased their membrane interactivities at pH 5.9-6.4 compared with pH 7.4. Such increases were greater in anionic phospholipid membranes which consisted of substantial amounts of cardiolipin and phosphatidylserine. Positively charged bupivacaine and lidocaine would form ion-pairs with the negatively charged head-groups of anionic phospholipids under acidic conditions, thereby increasing the induced membrane fluidization. The mitochondrial membrane interactions depending on pH lowering may be, at least in part, responsible for local anesthetic cardiotoxicity enhanced in acidosis associated with cardiac ischemia.
局麻药的心脏毒性在心肌缺血时增加,其特征为组织 pH 值降低至 6.5 或更低。除了心脏通道阻滞外,膜相互作用也被认为是其心脏毒性作用的另一种模式。通过使用仿生膜,我们验证了这样一个假设,即在类似于缺血的酸性条件下,布比卡因和利多卡因可能会越来越多地与心脏线粒体膜相互作用。仿生膜是用不同的磷脂和胆固醇制备的,它们是悬浮在 pH 值为 7.4、6.9、6.4 或 5.9 的缓冲液中的单层囊泡。将布比卡因和利多卡因与膜制剂在心脏毒性相关浓度下反应,并通过测量荧光偏振来测定其膜相互作用。这两种药物都与 100 mol% 1,2-二棕榈酰磷脂酰胆碱、周围神经细胞模拟和心肌细胞模拟膜相互作用,增加膜流动性,尽管将反应 pH 值从 7.4 降低至 5.9 会降低其膜增溶作用。然而,在含有 20 mol% 心磷脂的心肌线粒体模拟膜中,与 pH 值为 7.4 相比,布比卡因和利多卡因在 pH 值为 5.9-6.4 时反而增加了它们的膜相互作用。在阴离子磷脂膜中,这种增加更大,这些膜含有大量的心磷脂和磷脂酰丝氨酸。带正电荷的布比卡因和利多卡因会在酸性条件下与阴离子磷脂的带负电荷的头部基团形成离子对,从而增加诱导的膜增溶作用。依赖于 pH 值降低的线粒体膜相互作用至少部分是局麻药在与心肌缺血相关的酸中毒中增强的心脏毒性的原因。